3,200 templates cleared MLR in 2024

Social templates that survive
MLR on the first pass.

Pre-cleared pharma social templates for Instagram, LinkedIn, and HCP channels — ISI-compliant, fair-balance ready, OPDP-aware.

Instagram · Slide 1 of 6
MLR-CLEARED1080 × 1080px
Immunology · Phase III
HCP-Targeted Carousel

Demonstrated 47% reduction in disease progression

Phase III data in treatment-naïve patients with moderate-to-severe plaque psoriasis. N=846.

View Full Data →
ISI
Important Safety Information

IMPORTANT SAFETY INFORMATION: XEMPLAR (dupilumab-prx) is contraindicated in patients with known hypersensitivity. Most common adverse reactions (≥1%) include injection site reactions, conjunctivitis, and headache. See full Prescribing Information.

ISI ✓
Fair Balance ✓
OPDP-Aware ✓
FAIR BALANCE

RISKS: Anaphylaxis, serious infections, parasitic infections. BENEFITS: Significant reduction in PASI score vs placebo (p<0.001). See PI for complete benefit-risk profile.

Compliance Check

ISI included
Fair balance present
No off-label claims
Brand name + generic
Indication statement
PI reference linked
Use This Template
SCROLL TO EXPLORE
LIVE PLATFORM METRICS

3,200 templates launched through MLR.
Zero enforcement letters.

Every template ships with built-in compliance architecture — ISI footers, fair balance panels, and OPDP-aware copy rules baked in.

0+

Templates Cleared MLR

in 2024 alone

0%

First-Pass Approval Rate

vs. 61% industry avg

0.0days

Avg Review Cycle

vs. 14-day baseline

0.0OPDP letters

Enforcement Actions

across all clients

⚕️OPDP-Compliant Framework
🔒Fair Balance Auto-Included
Veeva PromoMats Ready
DDMAC-Era Proof Tested
📋ISI Footer Templates
🏥12 Therapeutic Areas
WORKFLOW ANALYSIS

22 days vs. 3 days.
Same compliance bar. Different starting point.

The bottleneck isn't MLR — it's the 72 hours before you submit. Prescribe eliminates the rebuild-from-scratch tax.

WITHOUT PRESCRIBE
avg 22 days · 3 revision rounds
01

Brief to agency

Day 1–2

Email thread, Slack, shared drive chaos

02

Creative buildBOTTLENECK

Day 3–5

Designer rebuilds ISI from last campaign

03

MLR submission

Day 6

PDF + 47-comment redline emailed to PromoMats

04

Round 1 feedbackBOTTLENECK

Day 12

Fair balance missing, ISI font too small, off-label flag

05

Revisions

Day 13–15

Back to designer, new version, re-brief

06

Round 2 reviewBOTTLENECK

Day 18

Legal hold — contract language concern

07

Final approval

Day 22+

If lucky. Often Round 3 starts here.

Total cycle time22+ days
WITH PRESCRIBE
avg 3.2 days · 94% first-pass
01

Select template

Minute 1

Filter by therapeutic area, format, platform

02

Customize copy

Minute 5

Brand color, headline, claim — ISI auto-populates

03

Compliance preview

Minute 6

Fair balance check, off-label scan, ISI validation

04

Export to PromoMats

Minute 8

One-click Veeva integration, audit trail attached

05

MLR submission

Day 1

Pre-cleared architecture — reviewers see zero flags

06

Approval

Day 3–4

Avg 3.2 days. First-pass 94% of the time.

Total cycle time3.2 days
PERFORMANCE METRICS

Five metrics. One clear winner.

Toggle between building from scratch and starting from a Prescribe template. The numbers do the convincing.

Time to Post

From brief to approved, ready-to-publish asset

22 days

MLR Rejection Rate

Percentage of submissions requiring at least one revision round

72%

Design Cost per Asset

Agency fees + internal time + revision rounds included

$4,200

Brand Consistency Score

Measured across ISI placement, color, typography, and claim structure

61/100

Team Bandwidth Used

Combined hours from brand manager, medical writer, designer, and MLR liaison

18 hrs

Data based on aggregate metrics across 48 mid-size pharma clients, Jan–Dec 2024. Individual results may vary by therapeutic area and internal MLR team structure.

GET STARTED

Your first template audit is free.
No commitment, no DDMAC flashback.

Tell us your therapeutic area and volume. We'll match you with a pre-cleared template library and show you exactly where your current workflow leaks time.

Start Your Free Template Audit

We'll identify which templates fit your pipeline in 24 hours

FREE
12550+

No credit card. No sales call unless you want one. Response within 24 hours.

Pharma Social Compliance Checklist

The 23-point MLR submission checklist used by Prescribe clients. ISI requirements, fair balance rules, OPDP enforcement patterns. Free PDF download.

ISI placement rules by platform
Fair balance minimum requirements
Off-label claim detection guide
OPDP enforcement letter patterns

Veeva PromoMats Compatible

All Prescribe templates export directly to PromoMats with audit trail and metadata pre-populated.